Unlock stock picks and a broker-level newsfeed that powers Wall Street.
LSE - Delayed Quote GBp

ConvaTec Group PLC (CTEC.L)

Compare
254.20
-5.20
(-2.00%)
As of 10:44:28 AM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Mr. Karim Bitar CEO & Director 3.07M -- 1965
Mr. Jonathan Peter Mason Group CFO & Director 1.64M -- 1964
Mr. John Haller Executive VP and Chief Quality & Operations Officer -- -- --
Dr. Divakar Ramakrishnan Ph.D. Executive VP, Chief Technology Officer and Head of Research & Development -- -- --
Mr. James Edward Spencer Kerton EVP, General Counsel & Company Secretary -- -- 1980
Ms. Emma Rose EVP & Chief People Officer -- -- --
Ms. Kjersti Grimsrud Biotechnology, M.Sc. President & COO of Infusion Care -- -- 1961
Mr. David Shepherd President & COO of Global Advanced Wound Care -- -- --
Mr. Seth R. Segel President and COO of Continence Care & Home Services Group -- -- 1969
Ms. Evelyn Douglas J.D. EVP and Chief Strategy & Business Development Officer -- -- --

ConvaTec Group PLC

20 Eastbourne Terrace
7th Floor
London, W2 6LG
United Kingdom
https://www.convatecgroup.com
Sector: 
Healthcare
Full Time Employees: 
10,489

Description

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Corporate Governance

ConvaTec Group PLC’s ISS Governance QualityScore as of April 1, 2025 is 2. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 1; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 26, 2025 at 7:00 AM UTC

ConvaTec Group PLC Earnings Date

April 17, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers